ÓÞ¹«ÒæÉÆ£¨ÓÞ¹«ÒÆɽ£©---¡¾ÓÞÓÞѧ԰¡¿µÄ·¢Õ¹ÐèÒªÄú×öµÄÄÇÒ»µã
¼¶±ð: У³¤

UID: 51011
¾«»ª: 23
·¢Ìû: 2974
ÍþÍû: 278 µã
»ý·Öת»»
ÓÞÓÞ±Ò: 9519 YYB
ÔÚÏß³äÖµ
¹±Ï×Öµ: 8 µã
ÔÚÏßʱ¼ä: 8720(Сʱ)
×¢²áʱ¼ä: 2008-09-21
×îºóµÇ¼: 2019-10-27
Â¥Ö÷  ·¢±íÓÚ: 2013-03-01 12:39

 Ãâ·ÑÒ©ÎïÊý¾Ý¿â

¹ÜÀíÌáÐÑ£º ±¾Ìû±» tianxangrong Ö´ÐмÓÁÁ²Ù×÷(2013-03-01)
¡¡
1. ÃÀ¹úFDAÒ©Æ·Êý¾Ý¿â£º
¡¡¡¡ÆäÍøַΪ: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/. Õâ¸öÊý¾Ý¿âÊÕ¼¯ÁËÃÀ¹úÉÏÊеÄËùÓÐÒ©Æ·É걨×ÊÁÏ. »ù±¾¼ìË÷·½·¨¿ÉÒÔʹÓÃÐÂÒ©ÉêÇëºÅ (New drug applicationnumber, NDA number), Ò©Æ·»îÐԳɷÖÃû (Active Ingredient), Ò©Æ·ÉÌÆ·Ãû (Drug Name) µÈ¼¸ÖÖ·½·¨À´¼ìË÷. ¸ß¼¶µÄ¼ìË÷·½·¨°üº¬ÁËÉÏÊö»ù±¾¼ìË÷·½·¨ÔÙ¼ÓÉÏʱ¼ä²ÎÊý.
¡¡¡¡2. ÃÀ¹úFDAÒ©Æ·¡± ³ÈÉ«Êý¾Ý¿â¡±(Electronic Orange Book)
¡¡¡¡ÆäÍøַΪ: http://www.fda.gov/cder/ob/default.htm. ±¾Êý¾Ý¿âº¬ÓÐÒ©ÎïµÈЧÐÔÆÀ¼ÛÐÅÏ¢,°üÀ¨ËùÓÐÒÑÅú×¼µÄÒ©Æ·. Æä»ù±¾¹¦ÄÜÓëFDAµÄÉÏÊÐÒ©Æ·Êý¾Ý¿âÏàËÆ, ¿ÉÒÔʹÓÃÐÂÒ©ÉêÇëºÅ (New drug application number, NDA number), Ò©Æ·»îÐԳɷÖÃû (Active Ingredient),, Ò©Æ·ÉÌÆ·Ãû (Drug Name), Ò©Æ·É걨»ú¹¹Ãû(Applicant holder), ҩƷרÀûºÅµÈ¼¸ÖÖ·½·¨À´¼ìË÷. ÔÚÐÂÒ©ÉêÇëºÅ, Ò©Æ·»îÐԳɷÖÃû, Ò©Æ·ÉÌÆ·Ãû, Ò©Æ·É걨»ú¹¹ÃûµÄÑ¡ÏîÏÂ,ÿÖмìË÷·½·¨¹ý°üº¬ÁË¡±´¦·½Ò©¡±,¡±·Ç´¦·½Ò©¡±(OTC), ¡°Í£Ö¹ÉÏÊÐÒ©¡±ÈýÖÖÑ¡ÔñÏî.
¡¡¡¡3. ÃÀ¹úFDAÉÏÊÐÒ©Æ·¼ìË÷ϵͳ£¨FDA Drug Index Database£©
¡¡¡¡ÕâÊÇÖйúÒ©ÎïÔÚÏßÍø£¨ http://www.drugfuture.com£©ÍƳöµÄFDAÉÏÊÐ Ò©Æ·¼ìË÷ƽ̨¡£¸ÃÊý¾Ý¿â°üº¬FDAµ½Ä¿Ç°ÎªÖ¹ÒÑÉÏÊлòÔø¾­ÉÏÊеÄÈ«²¿Ò©Æ·£¬°ïÖúÄú¿ìËÙ»ñ֪ijҩƷ¼°Ïà¹ØÒ©Æ·ÔÚÃÀ¹ú×¢²á¡¢ÉóÅú¡¢×¨ÀûµÈ·½ÃæµÄÖØÒªÐÅÏ¢¡£ÆäÍø Ò³ÊÇ£º http://www.drugfuture.com/fda/db1_query.asp¡£ÆäÌصãÊÇ£º
¡¡¡¡1¡¢Ö§³ÖÄ£ºý²éѯºÍ×éºÏ²éѯ,¸÷Ìõ¼þ¼ä¹ØϵΪÂß¼­Óë¡£ÀýÈçÔÚÒ©Æ·ÉÌÆ·ÃûÖÐÊäÈëLevofloxacin£¬¼´¿É²éѯËùÓÐÔÚÃÀ¹úÉÏÊеÄ×óÑõ·úɳÐÇÆ·ÖÖ¡£
¡¡¡¡2¡¢ÓÐЧ³É·ÖºÍÉÌÆ·Ãû²»ÄÜÉÙÓÚ3¸ö×Ö·û£¬ÐÂÒ©ÉêÇëºÅΪ6λÊý×Ö£¬¸ñʽΪnnnnnn¡£¸÷¼ìË÷Ìõ¼þÒâÒåÈçÏ£º
¡¡¡¡*ҩƷͨÓ*************************û»òÓÐЧ³É·Ö£ºDrug generic name\Active ingredient¡£
¡¡¡¡*ҩƷרÀûÒ©Ãû»òÉÌÆ·Ãû: Brand name¡£
¡¡¡¡*Ò©Æ·×¢²áÉêÇëºÅ£ºApplication number¡£
¡¡¡¡*Ò©Îï¼ÁÐÍ»ò¸øҩ;¾¶ osage form\route of administration
¡¡¡¡3¡¢¼ìË÷½á¹û°üÀ¨£º
¡¡¡¡*ÉÌÆ·Ãû(Ó¢ÎÄÃû)¡¢ÓÐЧ³É·Ö¡¢¼ÁÐÍ¡¢¹æ¸ñ¡¢ÉêÇëºÅ¡¢²úÆ·ºÅ¡¢Êг¡×´Ì¬¡¢TE´ú*****¡¢Åú×¼ÈÕÆÚ¡¢RLD´ú*****¡¢Ò©Æ·Àà±ð¡¢ÉêÇë»ú¹¹¡£
¡¡¡¡*¸ÃÒ©Æ·µÄÃÀ¹úרÀûºÅ£¬×¨ÀûʧЧÈÕÆÚ¡¢×¨ÀûÀà±ð£¬²¢¿ÉÖ±½ÓÒ»´ÎÐÔÍêÕûÏÂÔØרÀûÈ«ÎÄ£¬¸ñʽΪPDF»òTIFÁ½ÖÖ¡£
¡¡¡¡*Êг¡¶ÀռȨ±£»¤Çé¿ö£¬º¬¶ÀռȨÀàÐͼ°Ê§Ð§ÈÕÆÚ¡£
¡¡¡¡*Ò©Æ·×¢²áÉóÅúÐÅÏ¢£¬º¬È«²¿ÀúÊ·ÉóÅúÊý¾Ý£¬ÉóÅúʱ¼ä¡¢ÉóÅúÀà±ð¡¢Ò©Æ·ËµÃ÷Êé¡¢×ÛÊö¡¢Í¨Öª¼þµÈ¡£
¡¡¡¡4. PHRMAÁÙ´²Ñо¿ÖеÄÒ©ÎïÊý¾Ý¿â( http://newmeds.phrma.org/index.p ... pany=&status=3)
¡¡¡¡Today, over 2,000 newmedicines are in development. Many of these potential new medicines will failin clinical trials, but some may represent tomorrow's new treatments. Bringingeach new medicine to patients will require, on average, 10-15 years of testingand review. This database includes medicines currently in clinical trials or atFDA for review. The information contained in this database was derived fromWolters Kluwer Health's Adis R&D Insight and is published with permissionunder license with Wolters Kluwer Health. PhRMA has not reviewed or verifiedthis information.
¡¡¡¡5. ÁÙ´²Ñз¢ÖеÄÐÂÒ©Ë÷ÒýInfoknowmics™( http://www.infoknowmics.com/DrugIndex.html)
¡¡¡¡This index lists over 8900distinct drugs for the treatment and/or prevention of human diseases andmedical conditions. These products are part of our Infoknowmics™ Knowledgebasebecause they disclosed development activity in the past 9 years. The indexincludes all types of drugs across all clinical indications. It includes drugsthat are currently in the discovery, preclinical or clinical stages ofdevelopment, drugs that have been approved and launched during this timeperiod, as well those that have been discontinued.
¡¡¡¡For each product, we listits various names including the proprietary name (also called the brand name ortrade name), which is usually followed the trademark (™  or registeredtrademark (&reg  symbol. In addition, we provide the generic name (recommended orapproved by international and US nomenclature committees), as well as anyaliases which are typically laboratory code names, or new names assigned by alicensee or co-developer.
¡¡¡¡The type of each product isalso given. This category includes traditional product types, such as drugs,antibiotics, vaccines, and hormones, as well as newer types of products such aonoclonal antibodies and other types of recombinant proteins, celltherapeutics, gene therapy, DNA vaccines, antisense, and RNA interference-basedproducts.
¡¡¡¡Each product is indexed to its Originator Company, for intellectual property purposes. Please note thatbecause out-licensing, co-development or other types of partnerships may existfor each product, the Originator Company may not be the company currentlydeveloping the drug. The index was last updated on April 2, 2007 and can beviewed by Product Name or Product Type.
¡¡¡¡6. Ò©Îï·Ç»îÐԳɷÖÊý¾Ý¿â£¨Inactive Ingredient Searchfor Approved Drug Products£©
¡¡¡¡ÕâÊÇÖйúÒ©ÎïÔÚÏßÍø£¨ http://www.drugfuture.com£©ÍƳöµÄÃÀ¹úFDA Åú×¼Ò©Îï·Ç»îÐԳɷÖÊý¾Ý¿â.1¡¢±¾Êý¾Ý¿âΪFDAÅú×¼Ò©ÎïËùʹÓõķǻîÐԳɷÖÊý¾Ý¿â£¬¼´FDAÉÏÊвúÆ·Öаüº¬µÄ¸¨ÁÏÐÅÏ¢Êý¾Ý¡£2¡¢¼ìË÷Ìõ¼þÖ§³ÖÄ£ºý²éѯ£¬ ¸÷ÊäÈëÌõ¼þ¼äµÄ¼ìË÷¹ØϵΪÂß¼­Ó루¼´AND¹Øϵ£©¡£ 3¡¢¼ìË÷½á¹û°üÀ¨£º·Ç»îÐԳɷÖÃû³Æ¡¢¸øҩ;¾¶»ò¼ÁÐÍ¡¢CASµÇ¼ÇºÅ¡¢ÃÀ¹úÒ©µä/FDAÎïÖʵǼÇϵͳΨһ±êʶ*****¡¢´¦·½Öи¨ÁÏʹÓÃÁ¿¡£4¡¢ÀûÓñ¾Êý¾Ý¿â¿ÉÒÔΪҩÎïÑо¿¿ª·¢ÕßÌṩ¸¨ÁϵݲȫÓÃÁ¿µÄÊÂʵÐÔÊý¾Ý¡£¼ìË÷·½·¨°üÀ¨£º
¡¡¡¡*·Ç»îÐԳɷÖÃû³Æ(Inactive Ingredient)£»
¡¡¡¡*¸øҩ;¾¶»ò¼ÁÐÍ(Route; Dosage Form)£»
¡¡¡¡*CASµÇ¼ÇºÅ(CAS Number)£»
¡¡¡¡*Ψһ±êʶ*****(Unique Ingredient Identifier)
¡¡¡¡7. ¼ÓÄôóÒ©ÎïÒøÐР http://lims.drugbank.ca
¡¡¡¡ÆäÍøַΪ: http://lims.drugbank.ca/.¸ÃÊý¾Ý¿âº¬ÓÐÒ©Æ·µÄ»¯Ñ§,ÉúÎï×Ê ÁÏ, °üÀ¨Ò©Îï×÷ÓûúÖÆ, Ò©Æ·×÷ÓÃÊÜÌåÄ¿±ê. ¹²ÓÐ4300¶à¸öÒ©Îï. ÆäÖÐFDAÅú×¼µÄС·Ö×ÓÒ©ÎïÓÐ1200¶à¸ö, ÉúÎïÒ©ÎïÓÐ113¸ö. ÓªÑø¸¨ÖúÒ©Îï62¸ö, ÕýÔÚÁÙ´²ÊÔÑéµÄÒ©Îï3000¶à¸ö.
¡¡¡¡8. ÃÀ¹ú´¦·½Ò©Ë÷ÒýÍø, ÃÀ¹úÒ©Æ·Íø
¡¡¡¡ÕâÁ½¸öÍøÕ¾µÄÍøÖ··Ö±ðÊÇ£º http://www.rxlist.com/ ºÍ http://www.drugs.com£¬ÊôÓÚ´óÐ͵ÄҩƷ˵Ã÷Êé¼°Ò½Ò©, ÎÀÉú, ±£½¡ÖªÊ¶½éÉÜÍøÕ¾. ÄÚº¬´óÁ¿ÓйØÒ©Æ·µÄÐÅÏ¢
¡¡¡¡9. ÖйúÒ©ÍøµÄҩƷ˵Ã÷Êé:
¡¡¡¡ÆäÍøַΪ: http://www.chinapharm.com.cn/html/database/drugmanual/¸ÃÍøÕ¾ÊÕ¼¯Á˺ܶàҩƷ˵Ã÷Êé, ÆäҩƷ˵Ã÷ÊéµÄÍøÕ¾Ê×Ò³ÓÐÒ©Æ·µÄ·ÖÀàºÍÒ©Æ·¼ìË÷¹¦ÄÜ, ʹÓÃÆðÀ´ºÜ·½±ã. ´ËÍâ¸ÃÍøÕ¾»¹ÓÐÆäËûÓÐÓÃ×ÊÁÏÈç: Êг¡ÐÅÏ¢. Ò©Æ·ÐÂÎźÍÕþ¸®·¨¹æµÈ
¡¡¡¡10. Öйú¹ú¼ÒʳƷҩƷ¼à¶½¹ÜÀí¾Ö
¡¡¡¡ÆäÍøҳΪ£º http://www.sfda.gov.cn/WS01/CL0001/¡£ÕâÊÇÖйú¹ú¼ÒʳƷҩƷ¼à¶½¹ÜÀí¾ÖµÄÊý¾Ý¿âÈëÃÅÍøÒ³. Ö÷Òª°üº¬ÈçÏÂÄÚÈÝ:
¡¡¡¡*OTC»¯Ñ§Ò©Æ·ËµÃ÷Êé·¶±¾
¡¡¡¡*OTCÖÐҩ˵Ã÷Êé·¶±¾
¡¡¡¡*ִҵҩʦÈ϶¨Ãûµ¥
¡¡¡¡*Ò©°ü²ÄÉú²úÆóÒµÊý¾Ý¿â
¡¡¡¡*È«¹ú³·ÏúµÄÒ©Æ·¹ã¸æ
¡¡¡¡*ÉêÇëÈËÉ걨ÊÜÀíÇé¿ö
¡¡¡¡*Åú×¼µÄÒ©°ü²ÄÊý¾Ý¿â
¡¡¡¡*ÉÏÉýΪ¹ú¼Ò±ê×¼µÄÒ©Æ·Ãûµ¥
¡¡¡¡*Åú×¼ÁÙ´²Ñо¿µÄÐÂÒ©
¡¡¡¡*Ò©Æ·×¢²áÊÜÀíÐÅÏ¢
¡¡¡¡*Ò©Æ·×¢²áÅú×¼ÐÅÏ¢
¡¡¡¡*¿É·¢²¼´¦·½Ò©¹ã¸æµÄҽѧҩѧרҵ¿¯ÎïÃûµ¥
¡¡¡¡*Ò©Æ·×¢²áÅú¼þ·¢ËÍÐÅÏ¢
¡¡¡¡*¹ú¼Ò»ù±¾Ò©Î2004Ä꣩
¡¡¡¡*Ô¤·ÀÀàÉúÎïÖÆƷ˵Ã÷Êé
¡¡¡¡*Ò½ÁÆÆ÷е¼ì²âÖÐÐÄÊܼìĿ¼
¡¡¡¡*Ò©ÎïÁÙ´²ÊÔÑé»ú¹¹Ãûµ¥
¡¡¡¡*Ò½ÁÆÆ÷е·ÖÀàĿ¼ Ò½ÁÆÆ÷е±ê׼Ŀ¼
¡¡¡¡*ÁÙ´²Ç°Ñо¿µ¥Î»±¸°¸Ãûµ¥
¡¡¡¡*È«¹ú³·Ïú±£½¡Æ·¹ã¸æ
¡¡¡¡11. È«Êé:
¡¡¡¡ÆäÍøַΪ: http://www..com.ÊÇÒ»¸ö»ùì¶wiki¼¼ÊõµÄ¶àÓïÑԵİٿÆÈ«ÊéЭ×÷¼Æ»®£¬Ò²ÊÇÒ»²¿Óò»Í¬ÓïÑÔд³ÉµÄ°Ù¿ÆÈ«Ê飬ÆäÄ¿±ê¼°×ÚÖ¼ÊÇΪµØÇòÉϵÄÿһ¸öÈËÌṩ×ÔÓɵİٿÆÈ«Êé ¡ª¡ªÓÃËûÃÇÑ¡ÔñµÄÓïÑÔËùÊéдµÄ£¬È«ÊÀ½ç֪ʶµÄ×ܺ͡£È«Ê飬×Ô2001Äê1ÔÂ15ÈÕÕýʽ³ÉÁ¢£¬ÓÉά»ùýÌå»ù½ð»á¸ºÔðά³Ö£¬½ØÖÁ2007Äê8Ô£¬Î¬»ù °Ù¿ÆÌõÄ¿ÊýµÚÒ»µÄÓ¢ÎÄÒÑÓÐ190Íò¸öÌõÄ¿£¬¶øËùÓÐ253ÖÖÓïÑԵİ汾¹²Í»ÆÆ800Íò¸öÌõÄ¿. ´ó²¿·ÖÒ³Ã涼¿ÉÒÔÓÉÈκÎÈËʹÓÃä¯ÀÀÆ÷½øÐÐÔÄÀÀ¼°ÐÞ¸Ä. ËäÈ»ÓÐѧÕß»³ÒÉÆäÄÚÈݵÄ׼ȷÐԺͿÆѧÐÔ£¬µ«´ó²¿·ÖÄÚÈÝ»¹ºÜÊܿ϶¨µÄ. ÖÐÎÄì¶2002Äê10ÔÂ24ÈÕÕýʽ³ÉÁ¢.
±¾Ìû×î½üÆÀ·Ö¼Ç¼£º
  • ÓÞÓÞ±Ò:+20(cheminfo) лл·ÖÏí£¬¸ÐлУ³¤Ö§³Ö
  • ¼¶±ð: ±¾¿ÆÉú
    ״̬: δǩµ½ - [94Ìì/94´Î]
    UID: 117209
    ¾«»ª: 0
    ·¢Ìû: 60
    ÍþÍû: -2 µã
    »ý·Öת»»
    ÓÞÓÞ±Ò: 122 YYB
    ÔÚÏß³äÖµ
    ¹±Ï×Öµ: 0 µã
    ÔÚÏßʱ¼ä: 357(Сʱ)
    ×¢²áʱ¼ä: 2012-10-16
    ×îºóµÇ¼: 2018-12-21
    1Â¥  ·¢±íÓÚ: 2013-03-03 08:30

     »Ø Â¥Ö÷(tianxangrong) µÄÌû×Ó

    ºÜÓÐÓõÄÐÅÏ¢ÄØ£¬±£Áô
    ¼¶±ð: ²©Ê¿Éú
    ״̬: δǩµ½ - [539Ìì/539´Î]
    UID: 106036
    ¾«»ª: 0
    ·¢Ìû: 911
    ÍþÍû: 30 µã
    »ý·Öת»»
    ÓÞÓÞ±Ò: 82 YYB
    ÔÚÏß³äÖµ
    ¹±Ï×Öµ: 1 µã
    ÔÚÏßʱ¼ä: 4210(Сʱ)
    ×¢²áʱ¼ä: 2011-10-07
    ×îºóµÇ¼: 2016-03-09
    2Â¥  ·¢±íÓÚ: 2013-03-03 12:42
    ±£Áô£¬ÓÐÓã¡
    ¼¶±ð: ±¾¿ÆÉú
    ״̬: δǩµ½ - [32Ìì/32´Î]
    UID: 125063
    ¾«»ª: 0
    ·¢Ìû: 80
    ÍþÍû: 0 µã
    »ý·Öת»»
    ÓÞÓÞ±Ò: 39 YYB
    ÔÚÏß³äÖµ
    ¹±Ï×Öµ: 0 µã
    ÔÚÏßʱ¼ä: 102(Сʱ)
    ×¢²áʱ¼ä: 2015-01-17
    ×îºóµÇ¼: 2015-08-05
    3Â¥  ·¢±íÓÚ: 2015-01-22 11:10
    лл·ÖÎö·ÖÏí¡£¡£¡£¡£¡£
    Çë´ÍÓèÎÒÇ°½øµÄÁ¦Á¿£¬Ð»Ð»£¡
    ¼¶±ð: ¸±Ôº³¤
    ״̬: δǩµ½ - [1182Ìì/1182´Î]
    UID: 87715
    ¾«»ª: 0
    ·¢Ìû: 0
    ÍþÍû: 357 µã
    »ý·Öת»»
    ÓÞÓÞ±Ò: 1360 YYB
    ÔÚÏß³äÖµ
    ¹±Ï×Öµ: 0 µã
    ÔÚÏßʱ¼ä: 8184(Сʱ)
    ×¢²áʱ¼ä: 2010-03-11
    ×îºóµÇ¼: 2023-04-28
    4Â¥  ·¢±íÓÚ: 2015-01-26 10:53
    лл·ÖÎö·ÖÏí
    ¼¶±ð: ±¾¿ÆÉú
    ״̬: δǩµ½ - [32Ìì/32´Î]
    UID: 125063
    ¾«»ª: 0
    ·¢Ìû: 80
    ÍþÍû: 0 µã
    »ý·Öת»»
    ÓÞÓÞ±Ò: 39 YYB
    ÔÚÏß³äÖµ
    ¹±Ï×Öµ: 0 µã
    ÔÚÏßʱ¼ä: 102(Сʱ)
    ×¢²áʱ¼ä: 2015-01-17
    ×îºóµÇ¼: 2015-08-05
    5Â¥  ·¢±íÓÚ: 2015-02-02 13:31
    лл¥Ö÷£¬ÐÁ¿àÁË£¡
    Çë´ÍÓèÎÒÇ°½øµÄÁ¦Á¿£¬Ð»Ð»£¡
    ·ÖÏí:

    ÓÞÓÞѧ԰ÊôÓÚ´¿Ñ§Êõ¡¢·Ç¾­ÓªÐÔרҵÍøÕ¾£¬ÎÞÈκÎÉÌÒµÐÔÖÊ£¬´ó¼Ò³öÓÚѧϰºÍ¿ÆÑÐÄ¿µÄ½øÐн»Á÷ÌÖÂÛ¡£

    ÈçÓÐÉæÇÖ·¸Öø×÷ȨÈ˵İæȨµÈÐÅÏ¢£¬Ç뼰ʱÀ´ÐŸæÖª£¬ÎÒÃǽ«Á¢¿Ì´ÓÍøÕ¾ÉÏɾ³ý£¬²¢ÏòËùÓгְæȨÕßÖÂ×îÉîǸÒ⣬лл¡£